Drugplain

NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS 220 mg/1

Naproxen Sodium and Pseudoephedrine Hydrochloride · TABLET, EXTENDED RELEASE · VESPYR BRANDS LLC

No Recall History
Plain English

NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS is a tablet, extended release containing naproxen sodium and pseudoephedrine hydrochloride at 220 mg/1, taken oral. Manufactured by VESPYR BRANDS LLC.

Key Facts

Brand Name
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS
Generic Name
Naproxen Sodium and Pseudoephedrine Hydrochloride
NDC Code (Product)
71179-816
Manufacturer
VESPYR BRANDS LLC
Strength
220 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Marketing Status
Application #
ANDA211360
Marketing Start
08/07/2024

Recall History

No Recall History

Frequently Asked Questions

What is NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS used for?

NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS contains Naproxen Sodium and Pseudoephedrine Hydrochloride. It is a tablet, extended release taken oral. Consult your doctor for specific uses.

Is NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS a controlled substance?

NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS is not classified as a controlled substance by the DEA.

What is the generic name for NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS?

The generic name for NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS is Naproxen Sodium and Pseudoephedrine Hydrochloride. There are 3 other brand versions of Naproxen Sodium and Pseudoephedrine Hydrochloride.

What is the NDC code for NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS 220 mg/1?

The NDC (National Drug Code) for NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS 220 mg/1 is 71179-816, listed by VESPYR BRANDS LLC.

Product NDC

71179-816

Package NDC

71179-816-24

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)